Investing in transformative pharmaceutical and biotech ventures driving innovation and strategic growth.
Explore Our VenturesPhoenix Partners is a holding company focused on driving innovation in Uzbekistan’s pharmaceutical and biotechnology sectors.
To be the leading force transforming Uzbekistan’s healthcare sector through pioneering investments and global partnerships.
To identify and support high-potential pharma and biotech ventures that deliver sustainable health solutions and economic growth.
Phoenix Partners actively supports ventures that reshape Uzbekistan’s healthcare landscape through innovation, strategy, and investment.
Acquired pharmaceutical plant with new, unused equipment. Focus on solid dosage forms.
Establishing the first full-cycle pharmaceutical plasma industry. Enabled by recent presidential decrees.
Status: HaemaLogic (collection) expanding. HaemaTech (manufacturing) FEED Q4 2025.
Biotech company focusing on venom research (extraction, storage, lab studies) and scientific collaborations.
Status: Active partnerships with RENAM, Institute of Zoology, Shemyakin & Ovchinnikov Institute.
